Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
The Jazz Pharmaceuticals plc stock is trending slightly upwards today, with an increase of €1.05 (0.750%) compared to yesterday's price.
With 35 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 169 € there is a slightly positive potential of 18.47% for Jazz Pharmaceuticals plc compared to the current price of 142.65 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 0.750% | -2.160% | 20.941% | 20.787% | 22.341% | -1.102% | 17.893% |
| Repligen Corp. | -0.790% | -2.788% | 9.325% | -6.894% | -1.572% | -16.404% | -7.798% |
| Opko Health Inc. | 0.320% | 2.198% | 3.305% | -24.887% | -18.992% | -4.140% | -70.487% |
| Amicus Therapeutics Inc. | -0.600% | -1.190% | 4.403% | -13.089% | -9.290% | -24.145% | -54.144% |
Comments
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Wells Fargo & Company from $170.00 to $235.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Robert W. Baird from $160.00 to $209.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) was given a new $194.00 price target on by analysts at Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat